Clinical Trials Browser

Phase NA × Has results × Androgen Antagonists × Clear all

NCT01985828 2024-10-03

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Phase NA Completed

83 enrolled 7 charts

Prostatic Neoplasms